Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Fish and Richardson
Colorcon
Baxter
Harvard Business School
Julphar
UBS
Federal Trade Commission

Generated: June 21, 2018

DrugPatentWatch Database Preview

Lg Chem Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for LG CHEM LTD, and what generic alternatives to LG CHEM LTD drugs are available?

LG CHEM LTD has two approved drugs.

There are six US patents protecting LG CHEM LTD drugs.

There are seventy-one patent family members on LG CHEM LTD drugs in thirty-nine countries.

Summary for Lg Chem Ltd
International Patents:71
US Patents:6
Tradenames:2
Ingredients:2
NDAs:2
Drug Master File Entries: 6

Drugs and US Patents for Lg Chem Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 AB RX Yes Yes 6,803,376 ➤ Sign Up Y Y ➤ Sign Up
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 AB RX Yes Yes 6,723,734 ➤ Sign Up Y Y ➤ Sign Up
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 AB RX Yes Yes 6,455,540 ➤ Sign Up ➤ Sign Up
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 AB RX Yes Yes 6,262,071 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Lg Chem Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 6,723,734 ➤ Sign Up
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 5,633,262 ➤ Sign Up
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 5,962,468 ➤ Sign Up
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 5,776,944 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for LG CHEM LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 320 mg ➤ Subscribe 2008-03-04

Non-Orange Book US Patents for Lg Chem Ltd

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,595,328 Methods of use of quinolone compounds against pneumococcal and Haemophilus bacteria ➤ Sign Up
6,279,257 Flush mounting security frames and hardware ➤ Sign Up
6,938,154 System, method and article of manufacture for a cryptographic key infrastructure for networked devices ➤ Sign Up
7,700,617 Salt of naphthyridine carboxylic acid derivative ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
US Department of Justice
Johnson and Johnson
Covington
Julphar
Federal Trade Commission
Chubb
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.